Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Update on Levolux strategy

28 Jun 2019 11:00

RNS Number : 7295D
Alumasc Group PLC
28 June 2019
 

28 June 2019

The Alumasc Group plc (ALU.L) (the Group")

 

Update on Levolux strategy

 

Further to the Group's trading update on 14 June, the Board has now progressed its review of the optimal strategy for the continued development of Levolux as part of the broader Alumasc Group. The conclusions are set out below.

 

Levolux is a business with great future potential, both in the UK and international markets and is one of Alumasc's strongest brands.

 

The Board will focus the business where it believes it can clearly differentiate and add most value to customers and shareholders. This will involve developing the more profitable areas of the business, simplifying operational delivery and reducing risk with the key initial steps being to:

 

· combine Levolux solar shading, screening and balconies with the Group's roofing business in a new "Alumasc Building Envelope" division, providing integrated solutions for developers and specifiers seeking high quality roofing and facades systems. A new, collaborative divisional sales approach will increase Levolux's existing market reach and leverage existing strong customer relationships within the wider Group.

 

· focus on design and supply activities, with installation increasingly carried out by third party registered contractors as is the case in the rest of the Group. The vast majority of Levolux projects in the UK currently involve in-house installation which will in future only be offered where this service is particularly valuable to customers.

 

· invest in local technical sales resources to accelerate growth in the profitable Levolux business in North America, which currently generates revenues of circa £4 million p.a. on a design and supply only basis.

 

· optimise the utilisation of business locations across Alumasc to drive synergy and efficiency within the Building Envelope division. This forms part of the Group's broader strategy set out in its 2019 interim report and will enable greater sharing of common support services.

 

Alongside these initiatives the Company will reduce the break-even level of sales by increasing contribution margins and controlling overheads.

 

Initiatives to effect these changes will begin immediately and are expected to be largely implemented by the end of the coming financial year. Consequently, the Board's expectations for underlying performance in the year to June 2020 are unchanged, although the expectation is that this re-positioning will enhance the prospects for the Group in the medium term.

 

 

This announcement contains inside information for the purposes of Market Abuse Regulation (Regulation (EU) No. 596/2014). The person responsible for making this announcement on behalf of the Company is Helen Ashton, Group Company Secretary.

 

Enquiries:

The Alumasc Group plc +44 (0)1536 383 844

Paul Hooper (Chief Executive)

Andrew Magson (Group Finance Director)

 

Peel Hunt (Broker)

Mike Bell +44 (0)207 418 8831

 

FinnCap (NOMAD)

Julian Blunt +44 (0)207 220 0561

 

Camarco:

Ginny Pulbrook +44 (0)203 757 4992

Tom Huddart +44 (0)203 757 4991

Email: alumasc@camarco.co.uk

 

Notes to Editors:

Alumasc is a UK-based supplier of premium building products, systems and solutions. Almost 80% of group sales are driven by building regulations and specifications (architects and structural engineers) because of the performance characteristics offered.

 

The group has three business segments with strong positions and brands in their individual markets: Roofing & Water Management; Architectural Screening, Solar Shading & Balconies; and Housebuilding Products & Ancillaries.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSEDFMWFUSEDM
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.